Miki T - Search Results

1

Prognostic significance of thymidylate synthase activity in bladder carcinoma.

Mizutani Y, Wada H, Ogawa O, Yoshida O, Fukushima M, Nonomura N, Miki T. Mizutani Y, et al. Among authors: miki t. Cancer. 2001 Aug 1;92(3):510-8. doi: 10.1002/1097-0142(20010801)92:3<510::aid-cncr1349>3.0.co;2-0. Cancer. 2001. PMID: 11505394

2

The significance of dihydropyrimidine dehydrogenase (DPD) activity in bladder cancer.

Mizutani Y, Wada H, Fukushima M, Yoshida O, Ukimura O, Kawauchi A, Miki T. Mizutani Y, et al. Among authors: miki t. Eur J Cancer. 2001 Mar;37(5):569-75. doi: 10.1016/s0959-8049(00)00440-8. Eur J Cancer. 2001. PMID: 11290431

3

Significance of serum soluble Fas ligand in patients with bladder carcinoma.

Mizutani Y, Hongo F, Sato N, Ogawa O, Yoshida O, Miki T. Mizutani Y, et al. Among authors: miki t. Cancer. 2001 Jul 15;92(2):287-93. doi: 10.1002/1097-0142(20010715)92:2<287::aid-cncr1321>3.0.co;2-4. Cancer. 2001. PMID: 11466681

4

Potentiation of the sensitivity of renal cell carcinoma cells to TRAIL-mediated apoptosis by subtoxic concentrations of 5-fluorouracil.

Mizutani Y, Nakanishi H, Yoshida O, Fukushima M, Bonavida B, Miki T. Mizutani Y, et al. Among authors: miki t. Eur J Cancer. 2002 Jan;38(1):167-76. doi: 10.1016/s0959-8049(01)00339-2. Eur J Cancer. 2002. PMID: 11750847

5

Significance of dihydropyrimidine dehydrogenase activity in renal cell carcinoma.

Mizutani Y, Wada H, Yoshida O, Fukushima M, Nakanishi H, Nakao M, Miki T. Mizutani Y, et al. Among authors: miki t. Eur J Cancer. 2003 Mar;39(4):541-7. doi: 10.1016/s0959-8049(02)00730-x. Eur J Cancer. 2003. PMID: 12751387

6

Synergistic cytotoxicity and apoptosis by Apo-2 ligand and adriamycin against bladder cancer cells.

Mizutani Y, Yoshida O, Miki T, Bonavida B. Mizutani Y, et al. Among authors: miki t. Clin Cancer Res. 1999 Sep;5(9):2605-12. Clin Cancer Res. 1999. PMID: 10499639

7

Effects of epidermal growth factor on the invasion activity of the bladder cancer cell line.

Kanno N, Nonomura N, Miki T, Kojima Y, Takahara S, Nozaki M, Okuyama A. Kanno N, et al. Among authors: miki t. J Urol. 1998 Feb;159(2):586-90. doi: 10.1016/s0022-5347(01)63989-2. J Urol. 1998. PMID: 9649297

8

[Clinical study of carcinoma in situ of the urinary bladder].

Harada Y, Seguchi T, Nonomura N, Kojima Y, Miki T, Okuyama A. Harada Y, et al. Among authors: miki t. Nihon Hinyokika Gakkai Zasshi. 1998 Aug;89(8):693-7. doi: 10.5980/jpnjurol1989.89.693. Nihon Hinyokika Gakkai Zasshi. 1998. PMID: 9780653 Free article. Japanese.

9

Adriamycin-mediated potentiation of cytotoxicity against freshly isolated bladder cancer cells by autologous non-activated peripheral blood lymphocytes and tumor infiltrating lymphocytes.

Mizutani Y, Yoshida O, Miki T. Mizutani Y, et al. Among authors: miki t. J Urol. 1999 Dec;162(6):2170-5. doi: 10.1016/S0022-5347(05)68154-2. J Urol. 1999. PMID: 10569614

10

Prostate-specific transcription factor hPSE is translated only in normal prostate epithelial cells.

Nozawa M, Yomogida K, Kanno N, Nonomura N, Miki T, Okuyama A, Nishimune Y, Nozaki M. Nozawa M, et al. Among authors: miki t. Cancer Res. 2000 Mar 1;60(5):1348-52. Cancer Res. 2000. PMID: 10728697

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,913 results

Search Page

Filters